548 related articles for article (PubMed ID: 19269287)
21. 5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice.
Nunes-de-Souza V; Nunes-de-Souza RL; Rodgers RJ; Canto-de-Souza A
Behav Brain Res; 2008 Feb; 187(1):72-9. PubMed ID: 17935799
[TBL] [Abstract][Full Text] [Related]
22. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
[TBL] [Abstract][Full Text] [Related]
23. A comparative pharmacological study of trazodone, etoperidone and 1-(m-chlorophenyl)piperazine.
Cioli V; Corradino C; Piccinelli D; Rocchi MG; Valeri P
Pharmacol Res Commun; 1984 Jan; 16(1):85-100. PubMed ID: 6701182
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
Dhir A; Malik S; Kessar SV; Singh KN; Kulkarni SK
Eur Neuropsychopharmacol; 2011 Sep; 21(9):705-14. PubMed ID: 21277753
[TBL] [Abstract][Full Text] [Related]
25. Anti-depressant like activity of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (6o) a 5-HT3 receptor antagonist.
Bhatt S; Mahesh R; Devadoss T; Jindal A
Indian J Exp Biol; 2013 Jun; 51(6):435-43. PubMed ID: 23926691
[TBL] [Abstract][Full Text] [Related]
26. Antidepressant-like effects of the ethanolic extract of Xiaobuxin-Tang, a traditional Chinese herbal prescription in animal models of depression.
Zhang YZ; Li YF; Yu NJ; Yuan L; Zhao YM; Xiao WB; Luo ZP
Chin Med J (Engl); 2007 Oct; 120(20):1792-6. PubMed ID: 18028773
[TBL] [Abstract][Full Text] [Related]
27. Antidepressant activity of standardised extract of Marsilea minuta Linn.
Bhattamisra SK; Khanna VK; Agrawal AK; Singh PN; Singh SK
J Ethnopharmacol; 2008 Apr; 117(1):51-7. PubMed ID: 18299179
[TBL] [Abstract][Full Text] [Related]
28. Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission.
Binfaré RW; Rosa AO; Lobato KR; Santos AR; Rodrigues AL
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):530-40. PubMed ID: 19439241
[TBL] [Abstract][Full Text] [Related]
29. Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model.
Saitoh A; Yamada M; Yamada M; Takahashi K; Yamaguchi K; Murasawa H; Nakatani A; Tatsumi Y; Hirose N; Kamei J
Brain Res; 2008 May; 1208():160-9. PubMed ID: 18381208
[TBL] [Abstract][Full Text] [Related]
30. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
Stachowicz K; Kłodzińska A; Palucha-Poniewiera A; Schann S; Neuville P; Pilc A
Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634
[TBL] [Abstract][Full Text] [Related]
31. Effect of acute and chronic treatment with QCF-3 (4-benzylpiperazin-1-yl) (quinoxalin-2-yl) methanone, a novel 5-HT(3) receptor antagonist, in animal models of depression.
Devadoss T; Pandey DK; Mahesh R; Yadav SK
Pharmacol Rep; 2010; 62(2):245-57. PubMed ID: 20508279
[TBL] [Abstract][Full Text] [Related]
32. Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor.
Chaki S; Hirota S; Funakoshi T; Suzuki Y; Suetake S; Okubo T; Ishii T; Nakazato A; Okuyama S
J Pharmacol Exp Ther; 2003 Feb; 304(2):818-26. PubMed ID: 12538838
[TBL] [Abstract][Full Text] [Related]
33. Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models.
Gupta D; Radhakrishnan M; Thangaraj D; Kurhe Y
Eur J Pharmacol; 2014 Jul; 735():59-67. PubMed ID: 24747753
[TBL] [Abstract][Full Text] [Related]
34. Attenuating effects of testosterone on depressive-like behavior in the forced swim test in healthy male rats.
Buddenberg TE; Komorowski M; Ruocco LA; Silva MA; Topic B
Brain Res Bull; 2009 May; 79(3-4):182-6. PubMed ID: 19429189
[TBL] [Abstract][Full Text] [Related]
35. Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders.
Basso AM; Bratcher NA; Harris RR; Jarvis MF; Decker MW; Rueter LE
Behav Brain Res; 2009 Mar; 198(1):83-90. PubMed ID: 18996151
[TBL] [Abstract][Full Text] [Related]
36. Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests.
Andreasen JT; Olsen GM; Wiborg O; Redrobe JP
J Psychopharmacol; 2009 Sep; 23(7):797-804. PubMed ID: 18583432
[TBL] [Abstract][Full Text] [Related]
37. Antidepressant-like effect of the organoselenium compound ebselen in mice: evidence for the involvement of the monoaminergic system.
Posser T; Kaster MP; Baraúna SC; Rocha JB; Rodrigues AL; Leal RB
Eur J Pharmacol; 2009 Jan; 602(1):85-91. PubMed ID: 19026628
[TBL] [Abstract][Full Text] [Related]
38. Effect of the postsynaptic 5-HT1A receptor antagonist MM-77 on stressed mice treated with 5-HT1A receptor agents.
Alfredo BA; Ofir P
Eur J Pharmacol; 2005 Jan; 508(1-3):155-8. PubMed ID: 15680266
[TBL] [Abstract][Full Text] [Related]
39. Antidepressant-like effect of rutin isolated from the ethanolic extract from Schinus molle L. in mice: evidence for the involvement of the serotonergic and noradrenergic systems.
Machado DG; Bettio LE; Cunha MP; Santos AR; Pizzolatti MG; Brighente IM; Rodrigues AL
Eur J Pharmacol; 2008 Jun; 587(1-3):163-8. PubMed ID: 18457827
[TBL] [Abstract][Full Text] [Related]
40. The antidepressant-like activity of 6-methoxy-2-[4-(2-methoxyphenyl)piperazin-1-yl]-9H-xanthen-9-one involves serotonergic 5-HT(1A) and 5-HT(2A/C) receptors activation.
Pytka K; Walczak M; Kij A; Rapacz A; Siwek A; Kazek G; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B
Eur J Pharmacol; 2015 Oct; 764():537-546. PubMed ID: 26210317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
